PeptideStack
5.2kquestions
20kanswers
220users

Is a WXT order from Changsha likely to hold cold chain to South Africa?

Asked 26 Jan 2025Modified 18 months agoViewed 8.4k times
13

The specifics, since they change the answer: WXT · Changsha · South Africa.

I would like to set this up properly once, rather than adjust it repeatedly.

My budget is real but not tight, and my tolerance for uncertainty is low.

What would you do, and what would make you change course?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questionsinternational-shipping
international-shipping

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what…

471 questionsvendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
shareeditfollowflag
HN
askedhalvard_ness69k4726 Jan 2025
6What temperature, and for how long? Both are needed before anyone can say anything useful. – Dr_Rosalind_Achebe 3 months ago
7Do you know the residual moisture? It predicts this better than any date does. – Dr_Ingrid_Baumgartner 5 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 8.4k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.